Another Win for Mesothelioma Immunotherapy Drug Keytruda

There has been another win for one of the most promising new drugs for mesothelioma, the immunotherapy drug Keytruda (pembrolizumab). The makers of Keytruda today announced  that, when combined with the mesothelioma drug Alimta (pemetrexed) and the platinum-based drug cisplatin, it significantly extended the survival of lung cancer patients. According to Bloomberg, the news will likely make Keytruda an even more popular choice among immunotherapy … Continue reading Another Win for Mesothelioma Immunotherapy Drug Keytruda »

Long-Term Mesothelioma Survival with Mistletoe Extract

Mesothelioma researchers are calling for more study of compounds extracted from European mistletoe after a German pleural mesothelioma patient survived for more than four years with no other treatment. Pleural mesothelioma is an aggressive cancer caused by exposure to asbestos. Although many different types of new mesothelioma treatments are under investigation, there is no cure. An Alternative Mesothelioma Treatment? Most mesothelioma patients receive some combination … Continue reading Long-Term Mesothelioma Survival with Mistletoe Extract »

Radical Multi-Modal Mesothelioma Treatment: Is it Worth It?

Mesothelioma consultation regarding treatment

A team of Egyptian researchers is calling on mesothelioma doctors and patients to rethink their approach to treating this aggressive, asbestos-linked cancer. Scientists with Ain Shams University in Cairo conducted a review of studies on radical multi-modality approaches to malignant mesothelioma treatment and concluded that, despite what some other studies seem to suggest, this may not always be the best approach. What Are Radical Multi-Modal … Continue reading Radical Multi-Modal Mesothelioma Treatment: Is it Worth It? »

Bullfrog Eggs May Hold the Secret to Mesothelioma Survival

Researchers in Japan believe they may have discovered a new and more effective drug for the intractable asbestos cancer, malignant pleural mesothelioma – and it comes from an unlikely source. Sialic acid-binding lectin (cSBL) is a protein derived from the eggs of bullfrogs. It has the ability to bind to cell membranes and appears to exhibit antitumor activity through the degradation of RNA. Previous studies have … Continue reading Bullfrog Eggs May Hold the Secret to Mesothelioma Survival »

Predicting Mesothelioma Survival: A New Model

mesothelioma diagnosis

Could a geometric diagram hold the key to predicting the treatment outcomes of patients with malignant pleural mesothelioma? A team of thoracic surgery experts at China’s Fudan University believe the answer is yes. The team has developed such a diagram, called a nomogram, and used it to demonstrate the connection between a list of prognostic factors and actual mesothelioma survival. Predicting Mesothelioma Prognosis The new … Continue reading Predicting Mesothelioma Survival: A New Model »

CRS/HIPEC May Extend Survival in Rare Form of Peritoneal Mesothelioma

mesothelioma survivor

There has been an exciting new development in the treatment of one of the most aggressive forms of peritoneal mesothelioma. Biphasic mesothelioma is a variant of malignant mesothelioma that is even less responsive to standard cancer treatments than the more common epithelioid subtype. Many studies of peritoneal mesothelioma treatment have focused on people with the epithelioid form of the asbestos cancer, but much less is … Continue reading CRS/HIPEC May Extend Survival in Rare Form of Peritoneal Mesothelioma »

Modified Surgical Approach May Boost Pleural Mesothelioma Survival

For people with malignant pleural mesothelioma, surgery often offers the best odds of survival. But surgery can also come at a heavy cost in terms of pain, post-surgical side effects, and quality of life. Even lung-sparing pleurectomy with decortication, the least radical of the two major types of mesothelioma surgery, can cause life-threatening complications. But a new Italian study suggests that it may be possible … Continue reading Modified Surgical Approach May Boost Pleural Mesothelioma Survival »

Many Pleural Mesothelioma Patients May Be Missing Out on Life-Extending Treatments

Support for mesothelioma patients

Too many patients with malignant pleural mesothelioma are not getting the trimodality treatment protocol that could significantly change their outcomes. That is the finding of a newly-published study conducted at MD Anderson Cancer Center in Houston, Texas. Researchers reviewed the records of more than 20,000 patients in the National Cancer Database with a definitive diagnosis of pleural mesothelioma between 2004 and 2014. They discovered that, … Continue reading Many Pleural Mesothelioma Patients May Be Missing Out on Life-Extending Treatments »

Protein May Help Predict Complications After Peritoneal Mesothelioma Surgery

Researchers at MD Anderson Cancer Center say they may have found a way to help predict which peritoneal mesothelioma patients are most likely to develop complications after cytoreductive surgery and intraperitoneal chemotherapy. Cytoreductive surgery to remove as much of a mesothelioma tumor as possible, followed by a rinse of heated chemotherapy drugs in the abdomen is known as CRS + HIPEC. It has become a … Continue reading Protein May Help Predict Complications After Peritoneal Mesothelioma Surgery »

A New Approach to Reducing Mesothelioma Risk in Asbestos-Exposed People

The Japanese researchers who first suggested that removing iron from the body could help prevent malignant mesothelioma have come up with a way to make the process even easier and safer. In their original 2016 study, scientists at Nagoya University Graduate School of Medicine induced a pre-mesothelioma state in lab rats by injecting their abdomens with deadly crocidolite asbestos. As predicted, the rats exhibited all … Continue reading A New Approach to Reducing Mesothelioma Risk in Asbestos-Exposed People »

Get your free copy of
“Surviving Mesothelioma” Today!